Clinical Trial Update: Characterization of Cerebral Tau Aggregates With 18F-RO6958948 PET in the ALFA Population [NA]

View source ↗

Summary

An ongoing clinical trial is characterizing cerebral tau aggregates using the PET tracer 18F-RO6958948 in healthy individuals and those with mild cognitive impa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• 18F-RO6958948

Snippet

Sponsor: Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | Conditions: Healthy, Mild Cognitive Impairment | NA | Status: ENROLLING_BY_INVITATION